USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Tillotts Pharma AG

USPTO PatentsView assignee record - 25 granted patents across 4 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Tillotts ranks #12,268 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 4 technology areas.

#12,268
of 49,997 US assignees by volume
Top 37%
by Innovation Score (40.0/100)
20.3
avg claims per patent
+86%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12268 · Foreign Corporation #12,268 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 25 grants
  • UPPER-Q #12,268/49,997
  • PHOTO-FINISH Thermacell Repellents
  • CPC-NARROW A61K · 4 areas
  • INNOV-PAR 40.0/100
  • CLAIMS-DENSE 20.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +86% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Thermacell Repellents, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Tillotts’s 40.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Tillotts

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Tillotts's Innovation Score is 40.0/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Tillotts?

Each dot is one of Tillotts’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tillotts’s own 20.3 claims/patent is ABOVE the 15.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Tillotts vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 24.924.92525.1 0510152025 Granted patents (volume) Avg claims / patent Thermacell Repellents, Inc. - 25, 5.32Thermacell Repell…Thermedical, Inc. - 25, 20.32ThermedicalThetford LLC - 25, 7.88ThetfordThumbs Up Innovations Technology Co., Ltd. - 25, 1.76Thumbs Up Innovat…Tipping Point Group, LLC - 25, 17.12Tipping Point Gro…TriMed Inc. - 25, 23.56TrimedTriple Ring Technologies, Inc. - 25, 16.52Triple RingTrividia Health, Inc. - 25, 15.48Trividia HealthTillotts Pharma AG - 25, 20.28Tillotts Pharma
Tillotts vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Tillotts's grants concentrate

Tillotts Pharma AG is a focused PatentsView assignee: 4 CPC subclasses with 80% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (5 grants) versus a trough of 1 in 2016. By volume, Tillotts sits between Thermacell Repellents, Inc. and Trividia Health, Inc..

Tillotts's three-year grant acceleration

Tillotts Pharma AG shows 10 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Tillotts's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Tillotts holds 25 patents at rank #12,268, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Tillotts

By rank, the assignees closest to #12,268 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Tillotts's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Tillotts, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Tillotts ranks #1,122 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Tillotts's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 2016201720182019202020212022202320242025 5
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Tillotts Pharma AG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 4.0%
2017 1 4.0%
2018 1 4.0%
2019 4 16.0%
2020 1 4.0%
2021 2 8.0%
2022 5 20.0%
2023 2 8.0%
2024 3 12.0%
2025partial year 5 20.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Tillotts Pharma AG's patent record in context - here's where to go next.

  • Tillotts Pharma AG's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 80% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #12,268 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Tillotts Pharma AG against Thermacell Repellents, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 40.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.